Targeting capacity, safety and efficacy of engineered extracellular vesicles delivered by transdermal microneedles to treat plasmacytoma in mice

Enhanced tumor targeting: CD38-modified EVs (CD38-EVs) showed increased uptake by CD38high tumor cells while reducing uptake by CD38-negative non-tumor cells. Optimized delivery: MN-loaded CD38-EVs targeted tumors more effectively than MN-loaded EVs and intravenously injected CD38-EVs, with lower lung and spleen accumulation. Superior antitumor efficacy: MN-delivered CD38-EVs-Dox significantly suppressed tumor growth, outperforming intravenous CD38-EVs-Dox and MN-delivered EVs-Dox.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Medicine
Published
2025-05-01
DOI
https://doi.org/10.1002/ctm2.70327
Citations
6
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
4.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting capacity, safety and efficacy of engineered extracellular vesicles delivered by transdermal microneedles to treat plasmacytoma in mice

Jiao Qu, Wenlan Chen, B. S. Yang, Yaoying Long et al.
6 citations
Clinical and Translational Medicine
Extracellular vesicles in disease
4.84
article

Targeting capacity, safety and efficacy of engineered extracellular vesicles delivered by transdermal microneedles to treat plasmacytoma in mice

Jiao Qu, Wenlan Chen, B. S. Yang, Yaoying Long, Xuan Hu, Liuyue Xu, Qiubai Li, Lei Chen, Shan Wang, Hongxiang Wang, Zhichao Chen, Yong Deng, Yulin Cao, Di Wu, Yuxuan Jiang, Yali Yu, Blal Chakhabi
article en
6 citations

Abstract

Enhanced tumor targeting: CD38-modified EVs (CD38-EVs) showed increased uptake by CD38high tumor cells while reducing uptake by CD38-negative non-tumor cells. Optimized delivery: MN-loaded CD38-EVs targeted tumors more effectively than MN-loaded EVs and intravenously injected CD38-EVs, with lower lung and spleen accumulation. Superior antitumor efficacy: MN-delivered CD38-EVs-Dox significantly suppressed tumor growth, outperforming intravenous CD38-EVs-Dox and MN-delivered EVs-Dox.

Clinical and Translational MedicineVol. 15(5)
Union Hospital (HK), Hubei University of Science and Technology (CN), Wuhan National Laboratory for Optoelectronics (CN), Central Hospital of Wuhan (CN), Huazhong University of Science and Technology (CN)
National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 5%
Extracellular vesicles in disease
4.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.